Literature DB >> 34149995

Exosomes released from mesenchymal stem cells overexpressing microRNA-30e ameliorate heart failure in rats with myocardial infarction.

Lianmei Pu1, Xiangyun Kong2, Hong Li3, Xue He1.   

Abstract

AIM: Bone marrow-derived mesenchymal stem cells (BMMSCs) exert cardioprotective effects on myocardial infarction (MI). In this investigation, we elucidated the protective effects of BMMSCs-exosomes (Exo) expressing microRNA-30e (miR-30e) against heart failure (HF) in MI rats.
METHODS: First, the differentially expressed miRNAs were analyzed using a miRNA-based microarray of MI. Subsequently, we overexpressed miR-30e in rat BMMSCs to isolate exosomes. A rat model with MI was developed and treated with Exo. Next, we examined the cardiac function of the rats, followed by the myocardial tissue extraction. HE, TUNEL and Masson's staining were used to assess the protective effects of exosomes against HF in rats. Subsequently, H9C2 cells exposed to OGD were further co-cultured with Exo. We used bioinformatics to predict the target mRNA of miR-30e and verified the binding relationship. Finally, we tested the expression and role of NF-κB p65/Caspase-9 signaling in myocardial tissues and cells.
RESULTS: miR-30e was poorly expressed in myocardial tissues of MI rats. Moreover, treatment of rats with Exo overexpressing miR-30e ameliorated pathological damage, cardiomyocyte apoptosis, and fibrosis in rat myocardial tissues. Furthermore, miR-30e negatively regulated LOX1 expression, which was overexpressed in the MI rats, but further Exo treatment inhibited LOX1 expression. Moreover, Exo overexpressing miR-30e impaired the NF-κB p65/Caspase-9 signaling in myocardial tissues of MI rats. The NF-κB p65/Caspase-9 signaling inhibitor repressed the apoptosis and fibrosis of cardiomyocytes as well.
CONCLUSION: Exosomal miR-30e from rat BMMSCs markedly inhibited LOX1 expression, thereby downregulating the activity of the NF-κB p65/Caspase-9 signaling and ameliorating HF after MI in rats. AJTR
Copyright © 2021.

Entities:  

Keywords:  LOX1; Myocardial infarction; NF-κB p65/caspase-9 signaling; bone marrow-derived mesenchymal stem cells-derived exosome; heart failure; miRNA-30e

Year:  2021        PMID: 34149995      PMCID: PMC8205657     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  30 in total

1.  LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.

Authors:  Chunmei Zhang; Hailing Yang; Yan Li; Pengfei Huo; Piyong Ma
Journal:  Mol Cell Biochem       Date:  2020-02-18       Impact factor: 3.396

2.  Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.

Authors:  Qiang Su; Ziliang Ye; Yuhan Sun; Huafeng Yang; Lang Li
Journal:  Scand J Clin Lab Invest       Date:  2018-04-27       Impact factor: 1.713

Review 3.  The war against heart failure: the Lancet lecture.

Authors:  Eugene Braunwald
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321

4.  miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.

Authors:  Rudy F Duisters; Anke J Tijsen; Blanche Schroen; Joost J Leenders; Viola Lentink; Ingeborg van der Made; Veronica Herias; Rick E van Leeuwen; Mark W Schellings; Paul Barenbrug; Jos G Maessen; Stephane Heymans; Yigal M Pinto; Esther E Creemers
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

5.  China cardiovascular diseases report 2015: a summary.

Authors:  Wei-Wei Chen; Run-Lin Gao; Li-Sheng Liu; Man-Lu Zhu; Wen Wang; Yong-Jun Wang; Zhao-Su Wu; Hui-Jun Li; Dong-Feng Gu; Yue-Jin Yang; Zhe Zheng; Li-Xin Jiang; Sheng-Shou Hu
Journal:  J Geriatr Cardiol       Date:  2017-01       Impact factor: 3.327

Review 6.  Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis.

Authors:  Hyunsuk Jeong; Hyeon Woo Yim; Hun-Jun Park; Youngseung Cho; Hanter Hong; Na Jin Kim; Il-Hoan Oh
Journal:  Int J Stem Cells       Date:  2018-05-30       Impact factor: 2.500

Review 7.  A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction.

Authors:  Chi Miao; Mingming Lei; Weina Hu; Shuo Han; Qi Wang
Journal:  Stem Cell Res Ther       Date:  2017-11-02       Impact factor: 6.832

Review 8.  The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application.

Authors:  Teng Sun; Yan-Han Dong; Wei Du; Chun-Ying Shi; Kun Wang; Muhammad-Akram Tariq; Jian-Xun Wang; Pei-Feng Li
Journal:  Int J Mol Sci       Date:  2017-03-31       Impact factor: 6.208

9.  Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice.

Authors:  Yuto Nakamura; Shunbun Kita; Yoshimitsu Tanaka; Shiro Fukuda; Yoshinari Obata; Tomonori Okita; Hiroyuki Nishida; Yuki Takahashi; Yusuke Kawachi; Yuri Tsugawa-Shimizu; Yuya Fujishima; Hitoshi Nishizawa; Yoshinobu Takakura; Shigeru Miyagawa; Yoshiki Sawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Mol Ther       Date:  2020-07-08       Impact factor: 11.454

10.  Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage.

Authors:  Lifang Sun; Min Zhu; Wei Feng; Yiping Lin; Jia Yin; Juan Jin; Yunguang Wang
Journal:  Oxid Med Cell Longev       Date:  2019-12-16       Impact factor: 6.543

View more
  7 in total

1.  Mesenchymal Stem Cell-Derived Exosome-Loaded microRNA-129-5p Inhibits TRAF3 Expression to Alleviate Apoptosis and Oxidative Stress in Heart Failure.

Authors:  Fang Yan; Wei Cui; Ziying Chen
Journal:  Cardiovasc Toxicol       Date:  2022-05-12       Impact factor: 3.231

Review 2.  Mesenchymal Stromal Cell Exosomes in Cardiac Repair.

Authors:  Darukeshwara Joladarashi; Raj Kishore
Journal:  Curr Cardiol Rep       Date:  2022-01-29       Impact factor: 3.955

Review 3.  Roles of Exosomes in Cardiac Fibroblast Activation and Fibrosis.

Authors:  Julia Hohn; Wenbin Tan; Amanda Carver; Hayden Barrett; Wayne Carver
Journal:  Cells       Date:  2021-10-28       Impact factor: 6.600

Review 4.  Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke.

Authors:  Dirk M Hermann; Wenqiang Xin; Mathias Bähr; Bernd Giebel; Thorsten R Doeppner
Journal:  Theranostics       Date:  2022-07-18       Impact factor: 11.600

Review 5.  From cerebral ischemia towards myocardial, renal, and hepatic ischemia: Exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury.

Authors:  Wenqiang Xin; Yafei Qin; Ping Lei; Jianning Zhang; Xinyu Yang; Zengguang Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-24       Impact factor: 10.183

Review 6.  Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction.

Authors:  Jiacheng Fang; Yuxuan Zhang; Delong Chen; Yiyue Zheng; Jun Jiang
Journal:  Int J Nanomedicine       Date:  2022-10-04

Review 7.  The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years.

Authors:  Chan Wu; Binghong Liu; Ruiying Wang; Gang Li
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.